Company news

Share this article:
A spokesperson for GlaxoSmithKline told reporters that the company will make an announcement to US employees tomorrow about a reorganization, prompting press speculation about cuts to US-based sales forces.

Genzyme and Osiris Therapeutics have announced a partnership to develop and commercialize Prochymal and Chondrogen, two late-stage adult stem cell treatments. Osiris will commercialize the two treatments in the US and Canada, with Genzyme marketing the treatments in other countries.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.